PUBLICATION
INPP5K and SIL1 associated pathologies with overlapping clinical phenotypes converge through dysregulation of PHGDH
- Authors
- Hathazi, D., Cox, D., D'Amico, A., Tasca, G., Charlton, R., Carlier, R.Y., Baumann, J., Kollipara, L., Zahedi, R.P., Feldmann, I., Deleuze, J.F., Torella, A., Cohn, R., Robinson, E., Ricci, F., Jungbluth, H., Fattori, F., Boland, A., O'Connor, E., Horvath, R., Barresi, R., Lochmüller, H., Urtizberea, A., Jacquemont, M.L., Nelson, I., Swan, L., Bonne, G., Roos, A.
- ID
- ZDB-PUB-210402-6
- Date
- 2021
- Source
- Brain : a journal of neurology 144(8): 2427-2442 (Journal)
- Registered Authors
- Keywords
- BiP, INPP5K, PHGDH, SIL1, l-serine
- MeSH Terms
-
- Adolescent
- Adult
- Animals
- Child
- Female
- Guanine Nucleotide Exchange Factors/genetics*
- Humans
- Inositol Polyphosphate 5-Phosphatases/genetics*
- Male
- Middle Aged
- Muscle, Skeletal/pathology
- Mutation*
- Phenotype*
- Phosphoglycerate Dehydrogenase/genetics*
- Proteomics
- Spinocerebellar Degenerations/genetics*
- Spinocerebellar Degenerations/pathology
- Zebrafish
- PubMed
- 33792664 Full text @ Brain
Citation
Hathazi, D., Cox, D., D'Amico, A., Tasca, G., Charlton, R., Carlier, R.Y., Baumann, J., Kollipara, L., Zahedi, R.P., Feldmann, I., Deleuze, J.F., Torella, A., Cohn, R., Robinson, E., Ricci, F., Jungbluth, H., Fattori, F., Boland, A., O'Connor, E., Horvath, R., Barresi, R., Lochmüller, H., Urtizberea, A., Jacquemont, M.L., Nelson, I., Swan, L., Bonne, G., Roos, A. (2021) INPP5K and SIL1 associated pathologies with overlapping clinical phenotypes converge through dysregulation of PHGDH. Brain : a journal of neurology. 144(8):2427-2442.
Abstract
Marinesco-Sjögren syndrome (MSS) is a rare human disorder caused by biallelic mutations in SIL1 characterized by cataracts in infancy, myopathy and ataxia, symptoms that are also associated with a novel disorder caused by mutations in INPP5K. While these phenotypic similarities may suggest commonalties at a molecular level, an overlapping pathomechanism has not been established yet. In this study, we present six new INPP5K patients and expand the current mutational and phenotypical spectrum of the disease showing the clinical overlap between MSS and the INPP5K-phenotype. We applied unbiased proteomic profiling on cells derived from MSS- and INPP5K-patients and identified alterations in D-3-phosphoglycerate dehydrogenase as a common molecular feature. D-3-phosphoglycerate dehydrogenase modulates the production of L-serine and mutations in this enzyme were previously associated with a neurological phenotype, which clinically overlaps with MSS and INPP5K-disease. As, L-serine administration represents a promising therapeutic strategy for D-3-phosphoglycerate dehydrogenase patients, we tested the effect of L-serine in generated sil1, phgdh and inpp5k a + b zebrafish models which showed an improvement in their neuronal phenotype. Thus our study defines a core phenotypical feature underpinning a key common molecular mechanism in three rare diseases and reveals a common and novel therapeutic target for these patients.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping